PapersPMID:36982259
Beneficial Effect of Cuban Policosanol on Blood Pressure and Serum Lipoproteins Accompanied with Lowered Glycated Hemoglobin and Enhanced High-Density Lipoprotein Functionalities in a Randomized, Placebo-Controlled, and Double-Blinded Trial with Healthy Japanese.
- findings
- 4
- compound
- 1
- endpoints
- 4
- no difference found
- 2
- Study, every finding
- RCT · 3 months
- Dose studied, every finding
- 20 mg/day (two 10 mg tablets) for 12 weeks
What moved
How to read these marks →“In a group comparison during 12 weeks, the glycated hemoglobin level was 2% lower in the policosanol group than in the placebo group (p = 0.024).”
- Population
- Healthy Japanese adults aged 20 to 65 with normal blood pressure and LDL-C 120-160 mg/dL, advised on calorie, cholesterol, alcohol and exercise limits in both arms
- Increases HDL cholesterol
moderatereplicated ×2
“At week 12, the policosanol group showed a 9.5% higher HDL-C level (p < 0.001) than the placebo group (n = 17).”
- Population
- Healthy Japanese adults aged 20 to 65 with LDL-C 120-160 mg/dL; per-protocol subset excluding participants with low compliance, high-fat diet, heavy drinking or smoking
What did not
“Repeated measures ANOVA of TC, TG, LDL-C, and RC levels during the 12 weeks showed no difference between the policosanol group (n = 15) and the placebo group (n = 17) in terms of time and group interaction.”
- Participants
- 32
- Population
- Healthy Japanese adults aged 20 to 65 with LDL-C 120-160 mg/dL; per-protocol subset excluding participants with low compliance, high-fat diet, heavy drinking or smoking
- Participants
- 32
- Population
- Healthy Japanese adults aged 20 to 65 with LDL-C 120-160 mg/dL; per-protocol subset excluding participants with low compliance, high-fat diet, heavy drinking or smoking
Study record
- Design
- randomised controlled trial
- Species
- human / mixed
- Population
- Healthy Japanese adults 20-65 years with LDL-C 120-160 mg/dL and normal blood pressure; Raydel Cuban (sugarcane) policosanol 20 mg/day vs maltodextrin placebo for 12 weeks; lipid analyses in a compliant subset (policosanol n = 15, placebo n = 17). HDL functional assays include zebrafish embryo CML-injection model ex vivo.
- Participants
- 72
- Comparator
- placebo
- Duration
- 84 days
- Endpoints measured
- 77